Answer
Ethosuximide is expected to reach steady-state plasma concentrations 8–10 days after starting treatment.
Sources for this answer
- Ethosuximide Aristo 250mg/5ml oral solutionAristo Pharma Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 3Document updated
Sources checked